Cardiac voltage-sensitive optical mapping

• Use oxygenated Tyrode solution or comparable physiological perfusate for Langendorff-perfused hearts, because rat and human cardiac optical mapping studies used perfused isolated hearts maintained with physiological solution during dye loading and imaging.

• Use di-4-ANEPPS when mapping voltage in Langendorff-perfused rat, guinea-pig, or human heart preparations, because published studies used this dye to record optical action potentials and activation patterns.

• Use RH237 when simultaneous voltage and calcium optical mapping is required, because published dual-mapping protocols used a voltage dye with a calcium indicator and separated emitted fluorescence into non-overlapping detection channels.

• Use a Langendorff perfusion system, excitation light source, emission filters, high-speed camera or photodiode array, electrical stimulator, ECG or electrogram recording, and analysis software, because these components are reported in cardiac optical mapping studies for perfused hearts and multisite action-potential recording.

• Excise and cannulate the heart for retrograde Langendorff perfusion, maintain continuous oxygenated perfusion, and position the ventricular surface in the imaging field; this preparation has been used for rat, rabbit, guinea-pig, and explanted human cardiac optical mapping.

• Prepare the voltage-sensitive dye according to the selected published preparation: di-4-ANEPPS was used in rat and human Langendorff mapping, and RH237 was used in dual voltage-calcium mapping protocols.

• Reduce motion artifact before acquisition when needed, because cardiac motion can degrade optical signal fidelity;
• Mechanical stabilization was shown to reduce motion without distorting action potential characteristics, whereas excessive immobilizing force in rat sinus rhythm altered PQ interval and ventricular activation patterns.

• Load the heart with voltage-sensitive dye through the coronary circulation;
• Human Langendorff studies injected di-4-ANEPPS as a bolus, and rat Langendorff studies perfused hearts with di-4-ANEPPS before imaging activation and conduction.

• Excite di-4-ANEPPS fluorescence with green light and collect red-shifted emission when following the human Langendorff example, where excitation was 531 ± 20 nm, emission was long-pass filtered at 610 nm, and fractional fluorescence changes ranged from 2% to 12% with an average signal-to-noise ratio of 40 dB.

• Acquire optical movies at a sampling rate appropriate for the endpoint: 450-750 Hz can reconstruct plateau and final repolarization, whereas faster sampling is needed to resolve action-potential upstroke details.

• Apply programmed electrical stimulation when activation maps, conduction velocity, or restitution measurements are required, and compare pacing conditions consistently because optical mapping studies quantified activation patterns and conduction velocity under defined pacing or rhythm conditions.

• Calculate activation time from each optical action potential, construct activation maps, and estimate conduction velocity from the propagation of activation across the mapped field;
• Rat and human Langendorff studies used optical mapping to quantify activation patterns, conduction velocity, wavefront velocity, and reentrant or fractionating wavefronts.

• Measure action potential duration from normalized optical action potentials, but interpret values as tissue-level relative optical signals rather than direct intracellular microelectrode traces.

• Use electrical recordings or ECG as internal monitoring during experiments, because dye loading and mechanical stabilization can alter electrophysiological indices such as conduction velocity, PQ interval, or atrioventricular conduction in reported studies.

Problem: Optical action potentials show motion contamination.

• Possible cause: Beating motion changes the imaged tissue position during fluorescence recording.
• Literature-supported solution: Use validated mechanical stabilization, but avoid excessive force because excessive stabilization altered sinus-rhythm PQ interval and activation patterns in rat hearts.

Problem: Conduction velocity slows after dye loading.

• Possible cause: di-4-ANEPPS itself can alter impulse propagation.
• Literature-supported solution: Minimize dye exposure consistent with detectable signal and include dye-loaded controls, because 7.5 μM di-4-ANEPPS significantly decreased longitudinal and transverse conduction velocity in isolated guinea-pig hearts.

Problem: Optical signal is weak or noisy.

• Possible cause: Insufficient fluorescence change or inadequate optical configuration.
• Literature-supported solution: Confirm dye loading and match excitation/emission filters to the selected dye, because human Langendorff mapping with di-4-ANEPPS reported measurable 2%-12% fractional fluorescence changes using 531 ± 20 nm excitation and >610 nm emission detection.